P8A:SGX
Cordlife Group Ltd
0,12 SGD
0,00%
(0,00) 1 D
12. okt., 09:49:20 GMT+8 · SGD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for P8A …
Markedsverdi
32,37 mill.
Snittvolum
1,32k
Volum
0,00
52 u høy
0,26 SGD
52 u lav
0,10 SGD
EPS
−0,04 SGD
Utestående aksjer
267,53 mill.
Antall ansatte
111
Markedsverdi
32,37 mill.
Snittvolum
1,32k
Volum
0,00
52 u høy
0,26 SGD
52 u lav
0,10 SGD
EPS
−0,04 SGD
Utestående aksjer
267,53 mill.
Antall ansatte
111
Nyhetssaker
Fra nettkilder og nyhetspartnere
Vietnam.vn
·
for 1 døgn siden
Hurtiglesning 16-10: Dow Jones stiger over 550 poeng ettersom obligasjonsrentene faller, PV Power anslår et 9-måneders overskudd på over 5400 milliarder VND
StreetInsider
·
for 7 minutter siden
GreenPower converts $2M in debentures to preferred shares for Nasdaq compliance
Yahoo Finance
·
for 33 minutter siden
Wall Street’s record breakouts unravel as investors dump recent winners: Chart of the Day
Simply Wall Street
·
for 44 minutter siden
Did Genetic Response Data Just Shift Madrigal Pharmaceuticals (MDGL) Investment Narrative?
Profil
Cordlife Group Limited, is a consumer health company incorporated in May 2001 and a provider of cord blood and cord lining banking services in Asia. Cordlife has been listed on the mainboard of SGX since March 2012.
Cordlife Group owns the largest network of cord blood banks in Asia with full stem cell processing and storage facilities in six markets including Singapore, Hong Kong, India, Indonesia, and the Philippines. Beyond cord blood and cord lining banking, Cordlife offers diagnostics services, particularly for the mother and child segment, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.
Cordlife's stem cell processing and storage facilities in Singapore, Hong Kong, India, Indonesia, the Philippines and Malaysia were accredited by AABB until 2024 when its accreditation was withdrawn.
In November 2023, the Ministry of Health of Singapore revealed that Cordlife Group had exposed cryopreserved cord blood units at suboptimal temperatures, damaging the cord blood units belonging to at least 2,150 clients and rendering them unsuitable for stem cell transplant purposes. Wikipedia
Om Cordlife Group Ltd
Administrerende direktørYiu Pang Fai
Ansatte111
Grunnlagt2. mai 2001
Hovedkontor-
Sektor-
Nettstedcordlife.com